Corporate calendar for PepGen Inc. (PEPG): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $0.05 | $88M |
| 2026-09-15 | ||
| 2026-09-15 | $0.14 | $2.28B |
| 2026-09-15 |
Price
| Price | $2.90 |
| Market Cap | $201M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ALEC · APLT · CRBP · CRDF · CYBN · ELTX · FATE
Explore sector: Healthcare · Biotechnology
More sections of PEPG: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks